Published in Afr J Tradit Complement Altern Med on September 29, 2016
Honey & Nigella Sativa Trial Against COVID-19 (HNS-COVID-PK) | NCT04347382
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol (2004) 4.12
Antioxidant activity of Nigella sativa essential oil. Phytother Res (2000) 3.95
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology (2005) 3.71
Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis (2002) 3.19
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology (2004) 2.91
Pharmacological and toxicological properties of Nigella sativa. Phytother Res (2003) 2.78
Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology (2013) 2.62
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology (2007) 1.98
Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis (2003) 1.59
Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol (2005) 1.41
Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res (2000) 1.37
Social, behavioral, and biological factors, and sex differences in mortality. Demography (2010) 1.31
The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol (2002) 1.27
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat (2007) 1.02
Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A Physiol Pathol Clin Med (2001) 1.01
Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J Gastroenterol (2008) 1.00
Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res (2007) 1.00
Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res (2007) 0.98
Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res (2012) 0.97
Thymoquinone protects dopaminergic neurons against MPP+ and rotenone. Phytother Res (2009) 0.92
Effects of Nigella sativa on outcome of hepatitis C in Egypt. World J Gastroenterol (2013) 0.86
Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection. Hepat Mon (2010) 0.85
Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. Biochem Biophys Res Commun (2011) 0.83
Beneficial therapeutic effects of Nigella sativa and/or Zingiber officinale in HCV patients in Egypt. EXCLI J (2013) 0.78